FDA Inspection 1261687 — Elegant Direct Corp
The FDA completed an inspection of Elegant Direct Corp on Dec 2, 2024 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 2, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Brooklyn, NY (United States)